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Background: Inflammation of the conjunctiva due to allergy is known as 
allergic conjunctiva. It is also seen in the people suffering from allergic 
rhinitis and is affected by all age groups at least once in their lifetime. But 
older population and children are more prone for allergic conjunctivitis. 
Objectives: To evaluate the effect of Aschyotana karma or the therapy 
with Bilvadi eye drops in the management of Vataja abhishyanda (allergic 
conjunctivitis). Design: This was an observational study with random 
sampling. Forty subjects who fulfilled the eligibility criteria were 
included for the study. Patients with complaints of Allergic Conjunctivitis 
were selected from OPD of Department of Shalakya Tantra (Netra-Roga), 
R.G.G.P.G. Ayu. Hospital Paprola, Himachal Pradesh. These patients were 
administered Bilvadi aschyotana 2 eye drops 4to 5 times for 15 days and 
were assessed for itching, redness, burning sensation and photophobia 
before the treatment, on the 3rd day, once in a week and after the 
treatment.  
Results: Aschyotana with Bilvadi eye drops in Vataja abhishyanda 
provided significant relief in itching 70.09%, redness 41.7%, burning 
sensation 47.6% and photophobia 53.3%.  
 
INTRODUCTION 
Allergic conjunctivitis or conjunctival 
symptoms are present in 30-71% of patients with 
allergic rhinitis. Allergic conjunctivitis alone has 
been estimated in 6-30% of the general population 
and up to 30% in children alone or in association 
with allergic rhinitis. Seasonal allergic conjunctivitis 
is the most frequent form; however, studies from 
tertiary, ophthalmology referral centres report that 
the chronic forms, such as vernal and atopic kerato 
conjunctivitis, are the most frequently seen by 
ophthalmologists.[1] Older population studies 
estimate a prevalence of 15-20% of allergic 
conjunctivitis, but more recent studies implicate 
rates as high as 40%.[2]  
Allergic conjunctivitis (AC) is an 
inflammation of the conjunctiva due to allergy.[3] 
Allergic conjunctivitis (AC) is an inflammation of 
the conjunctiva secondary to an immune response 
to external antigens, usually called allergens. This 
inflammation could be IgE mediated and non-IgE 
mediated and atopy could play a significant role in 
clinical evolution.[4] AC is not a single disease; in fact 
it is a syndrome affecting the entire ocular surface, 
including conjunctiva, lids, cornea, and tear film.[5] 
Appropriate management of allergic conjunctivitis 
needs a correct diagnosis. Presence of itching is a 
hallmark of ocular allergy.[6] Though some authors 
have described management protocols, there are no 
universally accepted protocols of management for 
allergic eye diseases.[7,8] 
Various drugs are available and the 
treatment options vary based on the severity of the 
disease. It is important to avoid any known allergen 
or reduce exposure to it by using wrap around 
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glasses, by changing the environment, replacing 
allergen harboring items such as pillows and 
carpets. However, such recommendations may be 
challenging for patients. In addition, cool 
compresses can be done to prevent rubbing of the 
eye. Ocular lubricating eye drops can be used to 
dilute the inflammatory agents in tears and wash 
away the allergen to reduce itching and to prevent 
further worsening of symptoms.[9] 
The mainstay of treatment is the use of 
lubricants, anti-histamines and mast cell stabilisers. 
Steroids are to be given under proper medical care 
when the cornea is involved or the disease is very 
severe with itching.[6] 
Topical antihistamines competitively and 
reversibly block histamine receptors and relieve 
itching and redness but only for a short time.[10] 
Combination treatments using decongestants with 
antihistamines have been shown to be more 
effective, and are administered to the eye as drops 
up to 4 times daily.[11] 
Even alternative and complementary 
medicines speak about Allergic Conjunctivitis and it 
is called as Vataja Abhishyanda in Ayurvedic 
medicine. Its aetiology, symptoms, signs and the 
treatment has been explained in detail by the 
Acharyas of Ancient medicine. Kriyakalpas are the 
unique Ayurvedic therapies specially designed for 
the ophthalmic disorders and shown significant 
results through research studies. One such therapy 
is the Aschyotana which was administered in this 
study in patients who were suffering from Vataja 
abhishyanda to evaluate the effect of Bilvadi drops 
in the management of Vataja abhishyanda. 
MATERIAL AND METHODS  
Subjects 
This was an observational study with 
random sampling. Forty subjects who fulfilled the 
eligibility criteria were included for the study. 
Patients were selected from OPD of Department of 
Shalakya Tantra (Netra-Roga), R.G.G.P.G. Ayu. 
Hospital Paprola, Himachal Pradesh. Patients of 
Allergic conjunctivitis who attended O.P.D. during 
this study period were selected for the present 
study irrespective of age, caste, race and religion.  
Inclusion Criteria 
Patients who were diagnosed as Vataja 
Abhishyanda (Allergic Conjunctivitis) and willing to 
participate in the trial were included in the study.  
Exclusion Criteria 
Patients suffering from dry eye, Blepharitis, 
Trichiasis, Dacrocystitis, Chronic rhinitis and 
Trachoma, complicated conjunctivitis, people with 
other specific conjunctival diseases, and patients 
suffering from major systemic diseases like 
Diabetes, Hypertension where this type of 
treatment is not feasible and who are not willing for 
trial were excluded from the study.  
Design 
This was an observational study with 
random sampling. Forty subjects who fulfilled the 
eligibility criteria were included for the study. 
These patients were administered Bilvadi 
aschyotana 2 eye drops 4 to 5 times a day for 15 
days and were assessed before the treatment, on 
the 3rd day, once in a week and after the treatment. 
Only the subjective parameters were assessed and 
follow up was done after two months.  
Ethical clearance and consent 
The study was approved by the institutional 
ethical committee and signed informed consent was 
obtained from all patients. 
Outcome Measures 
Itching, redness, burning sensation and 
photophobia were assessed before the treatment, 
on the 3rd day, once in a week and after the 
treatment.  
Table 1: Gradation Index 
S.No. Outcome measures Grading 
1. Itching  
 No itching 0 
 Occasional tickle sensation not requiring to rub eye 1 
 Intermittent tickle sensation which require to rub eye 2 
 Continuous itch which require rubbing 3 
2. Redness/Congestion  
 No redness      0 
 Palpebral conjunctival congestion 1 
 Bulbar conjunctival congestion  2 
 Both palpebral & bulbar conjunctival congestion 3 
3. Burning sensation  
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 No burning sensation 0 
 Occasional Burning sensation  1 
 Intermittent burning sensation 2 
 Continuous burning sensation 3 
4. Photophobia  
 No photophobia 0 
 Occasional 1 
 Intermittent 2 
 Continuous 3 
Intervention 
Intervention included Poorva karma, Pradhana and the Paschat karma that is as follows: patient was 
made to lie down in supine position and relaxed in a place devoid of unpleasant breeze or the Nivata Sthana. 
The Vaidya was ready with the Ashchyotana Drava by filtering it through thick cotton pad or a clean cloth. 
The eye of the patient was opened with the left hand and administered the medicine drop by drop either 
with a seashell or a wick held in right hand from two fingers height just above Kaninika Sandhi or the inner 
canthus area. The medicine was retained in the eyes for 100 Matra Kala[12] or 155.28 seconds or 2.58 
minutes as mentioned in Ayurveda pharmacopeia of India.[13] The eyes then cleaned with soft cloth and 
observed for signs and symptoms of properly conducted Ashchyotana Karma such as Netra vaimalya 
(clearness of the eye), Vedana upashamana (relief of the pain), Vyadhi nivruti (cure of the disease) and Netra 
laghava (feeling of lightness in the eye).[14] As a Paschat karma, in case of Kapha and Vata predominant 
condition Mridu Swedana (mild fomentation) was done with a piece of cloth rinsed in warm water.    
RESULTS 
In the present study, 40 patients falling under inclusion criteria were registered. (Table No.2) 
Maximum number of patients were of age group 10-40 years (45%), were females (55%), married (75%), 
Hindu (100%), residents of rural area (100%), graduates (40%) and were taking vegetarian diet (67.5%). 
Majority of patients registered were that of Vata-Pittaja Prakriti (52.5%). Maximum number of patients had 
seasonal onset of disease (72.5%). Family history of any allergic disorder was reported in 37.5% patients.  
Table 2: Demographic Data 
Demographic parameters Assessment Percentage 
Age 10-40yrs 45%  
 41-50yrs 32% 
 51-60yrs 12.5% 
 61-70yrs 10% 
Sex Male 45% 
 Female 55% 
Religion Hindus 100% 
 Muslims 0 
 Christians 0 
Occupation House wives 40% 
 In service 35% 
 Students 20% 
 Retired 5% 
Habitat Urban 0 
 Rural 100% 
Education Graduates 40% 
 Post graduates 15% 
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 Matriculate 15% 
 Higher secondary education 12.5% 
 primary education 7.5%  
 Uneducated 10% 
Diet Mixed diet 32.5% 
 Vegetarian 67.5% 
Addiction No Addiction 87.5% 
 Addiction 12.5% 
Family history History of Allergy 37.5% 
 No History of Allergy 62.5% 
 Vata-pittaja Prakriti 52.5 % 
 Kapha-Vataja Prakriti 25% 
 Pitta-kaphaja 22.5 %. 
 Had onset of disease in season of summer 72.5% 
 Had perennial nature of the disease. 27.5% 
Effect of the Aschyotana therapy  
The Aschyotana therapy showed statistically significant results in relieving itching by 70.09%, redness by 
41.7%, burning sensation by 47.6% and photophobia by 53.3%.  
1. Itching: The initial mean score of itching was 2.675 before treatment and it reduced to 0.8 after 
treatment. The percentage relief was 70.09% which is highly significant at the level of p <0.001 
(t=18.304)  
2. Redness: The initial mean score of redness was 2.55 before treatment and it reduced to 1.5 after 
treatment. The percentage relief was 41.7 % which is highly significant at the level of p <0.001 
(t=10.400).  
3. Burning sensation: The initial mean score of photophobia was 2.1 before treatment and it reduced to 1.1 
after treatment. The percentage relief was 47.6% which is highly significant at the level of p<0.001 (t= 
10.55). 
4. Photophobia: The initial mean score of photophobia was before treatment 1.875 and it reduced to 0.875 
after treatment. The percentage relief was 53.3% which is highly significant at the level of p <0.001 
(t=8.832).  
Table 3: Results 
Parameters Mean Score D % age 
Relief 
SD ± SE± T P 
BT AT 
Itching 2.675 0.8 1.875 70.09 0.648 0.102 18.304 <0.001 
Redness 2.55 1.5 1.050 41.77 0.639 0.101 10.400 <0.001 
Burning sensation 2.1 1.1 1.000 47.62 0.599 0.0947 10.556 <0.001 
Photophobia 1.875 0.875 1.000 53.33 0.716 0.113 8.832 <0.001 
Table 4: Overall Effect of Therapy 
Result No. Of Patients Percentage 
Cured 0 0 
Markedly Improved 0 0 
Moderately Improved 23 57.5 
Mildly Improved 17 42.5 
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DISCUSSION  
In the present study 40 patients were 
registered. The diagnosis was done on the basis of 
signs and symptoms described in Ayurvedic and 
modern texts. The selected patients were given 
Bilvadi Aschyotana eye drops 2 drops 4 to 5 times a 
day for 15 days. During the trial, patients were 
assessed every week of treatment. For the 
assessment, both Ayurvedic and Modern 
parameters were followed. The results obtained 
were statistically analysed and mean percentage of 
relief, S.D., S.E. and t value by using the paired t test 
was calculated.  
In this study, it was observed that the 
maximum number of the patients, i.e., 45% were in 
the age group of 10-40 years which was in 
accordance to the finding of the modern science 
that the disease most commonly occurs in this age 
and these patients were exposed to dusty and 
polluted atmosphere. With respect to sex, majority 
were females 55% due to their household activities 
like cleaning, dusting etc and seen more in Hindus 
with 100%. 40% were house-wives, 100% patients 
were residents of rural area. 40% of patients were 
graduates, 32.5% with mixed diet, addiction to 
smoking was found in only 12.5% of patients, 
37.5% of them had family history of allergy that 
52.5% of them were of Vata-pittaja Prakriti, 25% 
Kapha-Vataja Prakriti followed by Pitta-kaphaja 
22.5%. In this clinical study majority of patients 
72.5% had onset of disease in season of summer 
whereas only 27.5% of patients had perennial 
nature of the disease.  
Acharyas have explained Abhishyanda as 
Sarvagata Vyadhi. All Acharyas are in same opinion 
regarding the disease Abhishyanda. Acharya quoted 
that Abhishyanda is the root cause of almost all the 
eye diseases. Conjunctivitis can be co-related with 
Abhishyanda on the basis of signs and symptoms. 
Acharyas also quoted that if Vataja Abhishyanda is 
not treated in time it leads to severe complication 
like Vatadhimantha ultimately resulting in 
Hatadhimantha that is Drishtinasha stage. Acharya 
Sushruta has recommended ‘Kriyakalpa’ for the 
management of Abhishyanda, along with other 
forms of treatment. The term Kriyakalpa refers to 
the treatment, which can be applied for almost all 
types of eye diseases; and it comprises of Tarpana, 
Putapaka, Seka, Ashchyotana, and Anjana. 
All Acharyas have given due importance to 
Kriyakalpas, but Acharya Vagbhatta quoted it as an 
Aadya Upakrama, the foremost procedure in 
treatment of all the eye diseases. It is said to be safe 
as well as most economical procedure. It eliminates 
the Doshas from all parts of eyes effectively. Special 
Ashchyotana formulations for Abhishyanda are 
available in Ayurvedic science. In Ashchyotana 
therapy, medicine is instilled drop by drop in 
Kaneenaka Sandhi which is highly vascularised area. 
Hence maximum absorption of the Ashchyotana 
Drava occurs in this area as compared to other 
areas of the eye. Among the various formulations 
prescribed for the treatment of Vataja Abhishyanda 
by different Acharyas, Bilvadi Aschyotana which is 
indicated in the treatment of Vataja Abhishyanda by 
Vagabhatta was selected for the present study. 
Kriyakalpas or topical ocular therapeutics is 
the uniqueness of Ayurvedic ophthalmology which 
include Parisheka /Seka, Aschyotana, and 
Tarpana.[15] Aschyotana is considered as the first 
line of treatment for all Netra rogas. The drug is 
topically delivered into cul-de-sac to achieve 
greater availability and local quicker action.[16] 
According to Ayurveda the instilled medicine will 
penetrate into the Akshikosha Srotas, Shira Srotas, 
Ghrana Srotas, and Mukha Srotas of the Urdhvanga 
Bhaga and remove the Mala present there.[17] 
Itching/Irritation of the eye 
 In this study, the initial mean score of 
itching/irritation of the eye were 2.675 before 
treatment and it reduced to 0.8 after treatment. The 
percentage relief was 70.09 which is highly 
significant at the level of p <0.001, (t=18.304).  
Redness 
In the present study, relief in redness was 
41.7% with initial mean score before 
commencement of trial 2.55 which comes down to 
1.5 after completion of trial which is statistically 
highly significant with p<0.001 and ( t=10.400). 
Burning sensation 
In the present study, the initial mean score 
of burning sensation before treatment was 2.1 and 
it reduced to 1.1 after treatment. The percentage 
relief was 47.6 which is highly significant at the 
level of p<0.001 (t= 10.55). 
Photophobia 
 In the present study, the initial mean score 
of photophobia before treatment was 1.875 and it 
reduced to 0.875 after treatment. The percentage 
relief was 48.73% which is highly significant at the 
level of p <0.001 (t=8.832).  
Overall effect 
23 patients were moderately improved i.e. 
57.5%, 17 patients had mild improvement i.e. 
42.5% and none of patient was cured or markedly 
improved.  
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One of the most simple and therapeutic 
modes of therapy are lubricating eye drops 
intended to relieve the symptoms of dry eyes due to 
decreased blink rates. Another study indicates that 
higher viscosity eye drops may be more beneficial 
than balanced salt solutions. Although the higher 
viscosity drops did not vary blink rates, they 
normalized the inter blink interval and relieved 
ocular discomfort more efficiently than balanced 
salt solutions following computer use. 
Unfortunately, these more viscous eye drops also 
cause a decrease in overall visual acuity. Common 
artificial tears are carboxy methyl cellulose and 
hydroxyl propyl cellulose. They contain water, salts 
and polymers but lack the proteins found in natural 
tears. Possible of adverse effects of carboxymethyl 
cellulose and other similar lubricants include eye 
pain, irritation, continued redness, or vision 
changes. Use should be discontinued if any of them 
occur. Those of hydroxypropyl cellulose include 
hyperemia, photophobia, stickiness of eyelashes, 
discomfort, and irritation. Long term use of 
preservatives present in some lubricating drops 
tears may harm the eye.[18] 
Whereas, Bilvadi eye drops that is used in 
the present study is of Ushna veerya and possess 
Vata-shamaka property where, Vata is the main 
Dosha involved in the disease Vataja abhishyanda. 
Moreover all the contents also have Shothahara 
property which helps in subsiding features like 
Alpa-shopha (mild chemosis) of Vataja abhishyanda. 
The Vednasthapana property of the ingredients 
helps in relieving Toda (pricking pain). Laghu, 
Ruksha guna of the drug helps in better penetration 
of the drug. Kshaya rasa of the contents promotes 
healing (Ropana) and reduces the discharges.  
 After absorption, Bilvadi Ashchyotana and 
Bilvadi eye drops may undergo systemic 
distribution primarily by nasal mucosa absorption 
and possibly by local ocular distribution by 
transcorneal/transconjunctival absorption, and 
metabolism by various enzymes. Hence, after 
instillation of Bilvadi Ashchyotana and Bilvadi eye 
drops, these fluids undergo absorption, distribution, 
and metabolism. Thus, the effect of Bilvadi 
Ashchyotana and Bilvadi eye drops are local as well 
as systemic.[17] 
Tannins present in Bilva have astringent 
properties. Most of the biological properties of 
tannins are linked to their ability to form complexes 
with macromolecules particularly with proteins 
(digestive and other enzymes, fungal or viral 
proteins). Tannin containing drugs precipitates 
protein and has been used traditionally as styptics 
and used for the protection of inflamed surfaces. 
Externally they waterproof the external layers of 
the skin and the mucosa thus protecting the 
underlying layers. They also have a vasoconstrictor 
effect on small superficial vessels. By limiting fluid 
losses and by preventing external aggressions 
tannins enhance tissue regeneration in case of 
superficial wound or burns. Tocopherol related 
compounds promote anti- oxidative activity at local 
site.  
Passage of Eye Drops: The passage of Bilvadi eye 
drops through the epithelium is determined by 
factors controlling the penetration of the drugs into 
other cells (Degree of dissociation of electrolytes). 
The absorption of Bilvadi Eye Drops in the eye can 
be mainly by 3 mechanisms, Ultra filtration, 
Diffusion and Active transport.  
Ultra filtration: Water and water soluble substance 
(limited by size & charge) passes through the micro 
pores in the cell membrane in response to an 
osmotic gradient or hydrostatic pressure. 
Diffusion: Lipid soluble substances are transported 
through the lipid portions of membrane 
proportional to the concentration gradient across 
the membrane. 
Active transport: Water soluble substances of 
large size and charge are actively transported 
across the cell membrane. This mechanism is 
believed to be mediated by globular proteins in the 
membrane & requires the expenditure of energy.  
Limitations of the study  
As the dose of the drops varies from person 
to person, uniformity in the dose cannot be 
maintained.  
Strengths of the Study  
Topical administration is preferred over the 
systemic mode for treating ocular diseases and 
conditions. It is simple to administer, easy to carry, 
relatively inexpensive and does not obscure vision. 
So patients prefer eye drop formulations. Packing in 
aseptic condition is also possible by modern ocular 
set up of pharmacy. Patients can maintain standard 
dose as instructed by the ophthalmologist. So, dose 
variation is minimal.  
ACKNOWLEDGEMENTS 
We sincerely acknowledge our thanks to all 
the staff of the Department of Shalakya Tantra, 
(Netra-Roga), R.G.G.P.G. Ayurveda Hospital, Paprola, 
Himachal Pradesh.  
CONCLUSIONS  
Aschyotana with Bilvadi eye drops showed 
significant results in relieving itching, redness, 
burning sensation and photophobia in patients 
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suffering from Vataja abhishyanda or the Allergic 
Conjunctivitis.  
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